<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Tue, 26 Aug 2025 16:49:23 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Tirzepatide leads to greater weight loss than semaglutide among adults with obesity</title><link>https://www.2minutemedicine.com/tirzepatide-leads-to-greater-weight-loss-than-semaglutide-among-adults-with-obesity/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/08/scale_edited-300x150.jpg</image_url><description>1. In this randomized controlled trial, among adults with obesity, it was found that tirzepatide resulted in a significantly greater reduction in body...</description><pubDate>Tue, 26 Aug 2025 19:00:39 GMT</pubDate></item><item><title>Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer</title><link>https://www.2minutemedicine.com/inavolisib-lengthens-progression-free-survival-time-in-her2-negative-advanced-breast-cancer-2/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2013/04/Mammogram_showing_breast_cancer-300x150.jpg</image_url><description>1. In this randomized controlled trial, in patients with PIK3CA-mutated advanced breast cancer, the addition of inavolisib to a palbociclib-fulvestran...</description><pubDate>Tue, 26 Aug 2025 15:00:18 GMT</pubDate></item><item><title>Pembrolizumab improves survival in locally advanced head and neck cancer</title><link>https://www.2minutemedicine.com/pembrolizumab-improves-survival-in-locally-advanced-head-and-neck-cancer/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/09/neck_edited-300x151.png</image_url><description>1. Among patients with locally advanced head and neck squamous-cell carcinoma (HNSCC), neoadjuvant and adjuvant pembrolizumab improved event-free surv...</description><pubDate>Tue, 26 Aug 2025 13:00:08 GMT</pubDate></item><item><title>Higher peak expiratory flow associated with decreased headache risk in middle-aged and older adults</title><link>https://www.2minutemedicine.com/higher-peak-expiratory-flow-associated-with-decreased-headache-risk-in-middle-aged-and-older-adults/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/08/chestfilm_edited-300x150.jpg</image_url><description>1. Higher peak expiratory flow was associated with a lower probability and lower risk of headache in middle-aged and older adults. Evidence Rating Lev...</description><pubDate>Tue, 26 Aug 2025 00:00:08 GMT</pubDate></item><item><title>#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis</title><link>https://www.2minutemedicine.com/visualabstract-personalised-gait-retraining-is-an-effective-non-surgical-treatment-for-medial-compartment-knee-osteoarthritis/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/08/2MM_08.17.25_Astrid_1_OA-300x300.jpg</image_url><description>Click here to read this study in the Lancet. Â©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written c...</description><pubDate>Mon, 25 Aug 2025 15:00:02 GMT</pubDate></item></channel></rss>